Tag: PSID

PSID, XIDE, CLNO & Extended Watchlist


We were extremely pleased with the the way PSID performed on our first ever day of coverage. It opened up at its low of day at .19, and closed up 26% at the high of day at .24, which we consider bullish activity. This confirms our call of the bottom, and really validates our interest in the stock moving forward. Bullish exhibitions like the one we observed yesterday often continue into multi-day gainers.

As you can see on the chart below, conditions appear even more favorable than they did yesterday, as indicators are pointing toward a stock in recovery. Ideally, we’d like to see higher lows with support holding at or above .20. Currently, we’re looking at resistance at the 20 and 50DMA’s of .27 and .33.

The company has been reaching out to the investment community via audio interviews recently as well. Lyle Probst, President of PSID subsidiary, Microfluidic Systems, appeared on SmallCap Voice on 06/04, and CEO William Caragol gave an exclusive interview on our sister site, StockTradersTalk.com.

Exide Technologies XIDE
We caught XIDE on our pre-market scanner on Monday after noticing that it had made a huge gap down, and was trading at 52-week lows for as little as .13. We continued to follow it in Tuesday’s report, as it had afforded us a chance at 65% in intraday gains the day prior. But it wasn’t finished there; XIDE would go on to hit a high of .299 on Tuesday, a 130% gain off of Monday’s low.

Congrats to anyone who was able to take advantage of this bottom call.

Cleantech Transit, Inc. CLNO
CLNO was trading subpenny when we first began watching it all the way back in March. At the time the stock was trading as low as .0055. We continued to following its progress, featuring it in an April report in which we stated that in the past, CLNO: “had a spike that ranged from the .03-area all the way up to .125, so we are well aware of the stock’s potential to make huge gains from current levels.” After just a few months, the stock has fulfilled our expectations, hitting a high of .09 yesterday, with gains from the .0055 bottom reaching a monstrous 1536%

Extended Watchlist:
MSTX (Gapping Down Near 52-week Low, Potential Bounceplay), BBDA, BMSN, ENTB, SNWT, INO,

PositiveID Corp. | PSID | Special Report

PositiveID Corporation  PSID

We are really excited about the upside potential of this morning’s featured company, PositiveID Corporation™ (OTCBB: PSID). The near-term on a ripening chart, as well as the long-term with an intriguing line of advanced technologies and high-level partnerships, are both looking decidedly bright for PSID.

As usual, we want to dive into the nuts and bolts of the company’s products before we take a look at the technicals of the chart. PositiveID’s futuristic line includes a number of different offerings, both existing and under development, that can really push the boundaries of point-of-care medical diagnostics, as well as real-time airborne pathogen and environmental contaminant detection.

 PositiveID Molecular Diagnostic Technologies:

The Microfluidics-based Bioagent Networked Detector (M-BAND), is a sample collection, processing and detection system that analyzes air samples for the purpose of rapid bacterial, viral and toxic detection. It then delivers the data in real-time via a connected network. The system was developed by the company’s MicroFluidic Systems subsidiary under contract with the U.S. Department of Homeland Security from ’04 to ’09, during which time it received governent funding on the order of $30M.

The DragonFly cartridge system provides cell lysis, nucleic acid purification, PCR amplification and fluorescent detection on biological samples for the purposes of identifying environmental bacteria, human papilloma virus (HPV), and antibiotic resistant bacteria such as MRSA.

FireFly, which is one of the technologies currently under development, will allow first-response teams to perform many of the same diagnostic tasks as its predecessors, using a handheld display device which communicates wirelessly via Bluetooth with a smartphone or computer.

There is rising demand for the kind of technologies PSID develops, as well as increased government spending. Anthrax and Ricin scares, SARS & H1N1 crises, and the looming threat of bio-terrorism and chemical warfare have all been contributing factors to increased funding.

Both M-BAND and FireFly will also be topics of discussion when Chief Technology Advisor Dr. Kimothy Smith presents for PSID at the 21st International Conference for Biodetection Technologies, as outlined in the PR you’ll find below.

Also worthy of mention, is PSID’s partnership with aerospace and defense behemoth, The Boeing Company. It is Boeing that has become PositiveID’s exclusive distributor of the M-BAND for the DHS $3.1 billion BioWatch Gen-3 program. With bedfellows like Boeing and Homeland Security, we are really hyped up about the possibilities that the future holds for PositiveID Corp.

PSID Chart:

We have taken the liberty of preparing an assessment of the current PSID chart in graphic and video formats for your viewing convenience.

We are turning our attention to PSID at a good time, with the stock trading at a relative bottom. As you can see on the chart below, conditions are just beginning to look primed for sizable gains. Currently we are looking at resistance at the 20DMA of .27, the 50DMA of .34, the 100DMA of .40, and the 200DMA of .44. Returning to these levels from its current price, would afford us gains ranging from 42-132%

This Morning’s PR:

DELRAY BEACH, Jun 13, 2013 (GLOBE NEWSWIRE via COMTEX) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced it has published an updated report on market opportunities and positioning for its M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) and its new Firefly Dx system (“Firefly”) technologies. The report is available on PositiveID’s website at positiveidcorp.com

You can also download the report directly from here.

Recent Important Announcement:

DELRAY BEACH, Fla., June 4, 2013 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCBB:PSID), a developer of biological detection and diagnostics solutions, today announced that Chief Technology Advisor Dr. Kimothy Smith is a featured presenter at the 21st International Conference for Biodetection Technologies 2013 in Alexandria, VA, at the Hilton Alexandria Mark Center Conference Center. Dr. Smith is scheduled to present at 4 pm ET on June 18, 2013, and will discuss the Company’s technological advances in the detection and identification of biological threats, specifically its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) and Firefly Dx detection system (“Firefly”).

More Information on PositiveID Corp, and its technologies an be found at: http://www.PositiveIDCorp.com.